APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhalation Pulmonary Drug Delivery Devices

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Inhalation Pulmonary Drug Delivery Devices Market Analysis and Forecast 2026-2032

29 December 2025191 pages

Choose your research edition.

Industry ResearchInhalation Pulmonary Drug Delivery Devices Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhalation Pulmonary Drug Delivery Devices Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Inhalation Pulmonary Drug Delivery Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhalation Pulmonary Drug Delivery Devices Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhalation Pulmonary Drug Delivery Devices Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Inhalation Pulmonary Drug Delivery Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Inhalation Pulmonary Drug Delivery Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Inhalation Pulmonary Drug Delivery Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Inhalation Pulmonary Drug Delivery Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Inhalation Pulmonary Drug Delivery Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Inhalation Pulmonary Drug Delivery Devices include AptarGroup, Boehringer Ingelheim, Chiesi Farmaceutici, H&T Presspart, Koninklijke Philips, Monaghan Medical, OMRON, PARI International and Vectura, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Inhalation Pulmonary Drug Delivery Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Inhalation Pulmonary Drug Delivery Devices, also provides the sales of main regions and countries. Of the upcoming market potential for Inhalation Pulmonary Drug Delivery Devices, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Inhalation Pulmonary Drug Delivery Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Inhalation Pulmonary Drug Delivery Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Inhalation Pulmonary Drug Delivery Devices sales, projected growth trends, production technology, application and end-user industry.

Inhalation Pulmonary Drug Delivery Devices Segment by Company

AptarGroup

Boehringer Ingelheim

Chiesi Farmaceutici

H&T Presspart

Koninklijke Philips

Monaghan Medical

OMRON

PARI International

Vectura

AstraZeneca

GlaxoSmithKline (GSK)

Viatris

Merck

Novartis

Teva Pharmaceutical Industries

Inhalation Pulmonary Drug Delivery Devices Segment by Type

Nebulizers

Dry-powder Inhalers

Metered- dose Inhalers

Inhalation Pulmonary Drug Delivery Devices Segment by Application

Chronic Obstructive Pulmonary Disease (COPD)

Cystic Fibrosis (CF)

Idiopathic Pulmonary Fibrosis (IPF)

Asthma

Others

Inhalation Pulmonary Drug Delivery Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalation Pulmonary Drug Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhalation Pulmonary Drug Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalation Pulmonary Drug Delivery Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Inhalation Pulmonary Drug Delivery Devices in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Inhalation Pulmonary Drug Delivery Devices manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Inhalation Pulmonary Drug Delivery Devices sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Inhalation Pulmonary Drug Delivery Devices Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Nebulizers Major Manufacturers Table 3. Dry-powder Inhalers Major Manufacturers Table 4. Metered- dose Inhalers Major Manufacturers Table 5. Global Inhalation Pulmonary Drug Delivery Devices Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Chronic Obstructive Pulmonary Disease (COPD) Major Manufacturers Table 7. Cystic Fibrosis (CF) Major Manufacturers Table 8. Idiopathic Pulmonary Fibrosis (IPF) Major Manufacturers Table 9. Asthma Major Manufacturers Table 10. Others Major Manufacturers Table 11. Inhalation Pulmonary Drug Delivery Devices Industry Trends Table 12. Inhalation Pulmonary Drug Delivery Devices Industry Drivers Table 13. Inhalation Pulmonary Drug Delivery Devices Industry Opportunities and Challenges Table 14. Inhalation Pulmonary Drug Delivery Devices Industry Restraints Table 15. Global Inhalation Pulmonary Drug Delivery Devices Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Region (2021-2026) Table 19. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Region (2027-2032) Table 20. Global Inhalation Pulmonary Drug Delivery Devices Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Inhalation Pulmonary Drug Delivery Devices Sales by Region (2021-2026) & (K Units) Table 22. Global Inhalation Pulmonary Drug Delivery Devices Sales by Region (2027-2032) & (K Units) Table 23. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Region (2021-2026) Table 24. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Region (2027-2032) Table 25. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Inhalation Pulmonary Drug Delivery Devices Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Manufacturers (2021-2026) Table 29. Global Inhalation Pulmonary Drug Delivery Devices Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Inhalation Pulmonary Drug Delivery Devices Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Inhalation Pulmonary Drug Delivery Devices Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Inhalation Pulmonary Drug Delivery Devices Manufacturers, Product Type & Application Table 33. Global Inhalation Pulmonary Drug Delivery Devices Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Inhalation Pulmonary Drug Delivery Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Type (2021-2026) Table 40. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Type (2027-2032) Table 41. Global Inhalation Pulmonary Drug Delivery Devices Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2026) & (K Units) Table 43. Global Inhalation Pulmonary Drug Delivery Devices Sales by Type (2027-2032) & (K Units) Table 44. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Type (2021-2026) Table 45. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Type (2027-2032) Table 46. Global Inhalation Pulmonary Drug Delivery Devices Price by Type (2021-2026) & (US$/Unit) Table 47. Global Inhalation Pulmonary Drug Delivery Devices Price by Type (2027-2032) & (US$/Unit) Table 48. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Application (2021-2026) Table 52. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Application (2027-2032) Table 53. Global Inhalation Pulmonary Drug Delivery Devices Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2026) & (K Units) Table 55. Global Inhalation Pulmonary Drug Delivery Devices Sales by Application (2027-2032) & (K Units) Table 56. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Application (2021-2026) Table 57. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Application (2027-2032) Table 58. Global Inhalation Pulmonary Drug Delivery Devices Price by Application (2021-2026) & (US$/Unit) Table 59. Global Inhalation Pulmonary Drug Delivery Devices Price by Application (2027-2032) & (US$/Unit) Table 60. AptarGroup Company Information Table 61. AptarGroup Business Overview Table 62. AptarGroup Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. AptarGroup Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 64. AptarGroup Recent Development Table 65. Boehringer Ingelheim Company Information Table 66. Boehringer Ingelheim Business Overview Table 67. Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 69. Boehringer Ingelheim Recent Development Table 70. Chiesi Farmaceutici Company Information Table 71. Chiesi Farmaceutici Business Overview Table 72. Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 74. Chiesi Farmaceutici Recent Development Table 75. H&T Presspart Company Information Table 76. H&T Presspart Business Overview Table 77. H&T Presspart Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. H&T Presspart Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 79. H&T Presspart Recent Development Table 80. Koninklijke Philips Company Information Table 81. Koninklijke Philips Business Overview Table 82. Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 84. Koninklijke Philips Recent Development Table 85. Monaghan Medical Company Information Table 86. Monaghan Medical Business Overview Table 87. Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 89. Monaghan Medical Recent Development Table 90. OMRON Company Information Table 91. OMRON Business Overview Table 92. OMRON Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. OMRON Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 94. OMRON Recent Development Table 95. PARI International Company Information Table 96. PARI International Business Overview Table 97. PARI International Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. PARI International Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 99. PARI International Recent Development Table 100. Vectura Company Information Table 101. Vectura Business Overview Table 102. Vectura Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Vectura Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 104. Vectura Recent Development Table 105. AstraZeneca Company Information Table 106. AstraZeneca Business Overview Table 107. AstraZeneca Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. AstraZeneca Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 109. AstraZeneca Recent Development Table 110. GlaxoSmithKline (GSK) Company Information Table 111. GlaxoSmithKline (GSK) Business Overview Table 112. GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 114. GlaxoSmithKline (GSK) Recent Development Table 115. Viatris Company Information Table 116. Viatris Business Overview Table 117. Viatris Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Viatris Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 119. Viatris Recent Development Table 120. Merck Company Information Table 121. Merck Business Overview Table 122. Merck Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Merck Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 124. Merck Recent Development Table 125. Novartis Company Information Table 126. Novartis Business Overview Table 127. Novartis Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Novartis Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 129. Novartis Recent Development Table 130. Teva Pharmaceutical Industries Company Information Table 131. Teva Pharmaceutical Industries Business Overview Table 132. Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 134. Teva Pharmaceutical Industries Recent Development Table 135. North America Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2021-2026) & (US$ Million) Table 136. North America Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2027-2032) & (US$ Million) Table 137. North America Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2026) & (K Units) Table 138. North America Inhalation Pulmonary Drug Delivery Devices Sales by Type (2027-2032) & (K Units) Table 139. North America Inhalation Pulmonary Drug Delivery Devices Sales Price by Type (2021-2026) & (US$/Unit) Table 140. North America Inhalation Pulmonary Drug Delivery Devices Sales Price by Type (2027-2032) & (US$/Unit) Table 141. North America Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2021-2026) & (US$ Million) Table 142. North America Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2027-2032) & (US$ Million) Table 143. North America Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2026) & (K Units) Table 144. North America Inhalation Pulmonary Drug Delivery Devices Sales by Application (2027-2032) & (K Units) Table 145. North America Inhalation Pulmonary Drug Delivery Devices Sales Price by Application (2021-2026) & (US$/Unit) Table 146. North America Inhalation Pulmonary Drug Delivery Devices Sales Price by Application (2027-2032) & (US$/Unit) Table 147. North America Inhalation Pulmonary Drug Delivery Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. North America Inhalation Pulmonary Drug Delivery Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. North America Inhalation Pulmonary Drug Delivery Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. North America Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 151. North America Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2026) & (K Units) Table 152. North America Inhalation Pulmonary Drug Delivery Devices Sales by Country (2027-2032) & (K Units) Table 153. North America Inhalation Pulmonary Drug Delivery Devices Sales Price by Country (2021-2026) & (US$/Unit) Table 154. North America Inhalation Pulmonary Drug Delivery Devices Sales Price by Country (2027-2032) & (US$/Unit) Table 155. United States Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 156. Canada Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 157. Mexico Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 158. Europe Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2021-2026) & (US$ Million) Table 159. Europe Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2027-2032) & (US$ Million) Table 160. Europe Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2026) & (K Units) Table 161. Europe Inhalation Pulmonary Drug Delivery Devices Sales by Type (2027-2032) & (K Units) Table 162. Europe Inhalation Pulmonary Drug Delivery Devices Sales Price by Type (2021-2026) & (US$/Unit) Table 163. Europe Inhalation Pulmonary Drug Delivery Devices Sales Price by Type (2027-2032) & (US$/Unit) Table 164. Europe Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2021-2026) & (US$ Million) Table 165. Europe Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2027-2032) & (US$ Million) Table 166. Europe Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2026) & (K Units) Table 167. Europe Inhalation Pulmonary Drug Delivery Devices Sales by Application (2027-2032) & (K Units) Table 168. Europe Inhalation Pulmonary Drug Delivery Devices Sales Price by Application (2021-2026) & (US$/Unit) Table 169. Europe Inhalation Pulmonary Drug Delivery Devices Sales Price by Application (2027-2032) & (US$/Unit) Table 170. Europe Inhalation Pulmonary Drug Delivery Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. Europe Inhalation Pulmonary Drug Delivery Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. Europe Inhalation Pulmonary Drug Delivery Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. Europe Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 174. Europe Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2026) & (K Units) Table 175. Europe Inhalation Pulmonary Drug Delivery Devices Sales by Country (2027-2032) & (K Units) Table 176. Europe Inhalation Pulmonary Drug Delivery Devices Sales Price by Country (2021-2026) & (US$/Unit) Table 177. Europe Inhalation Pulmonary Drug Delivery Devices Sales Price by Country (2027-2032) & (US$/Unit) Table 178. Germany Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 179. France Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 180. U.K. Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 181. Italy Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 182. Russia Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 183. Spain Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 184. Netherlands Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 185. Switzerland Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 186. Sweden Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 187. Poland Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 188. China Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2021-2026) & (US$ Million) Table 189. China Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2027-2032) & (US$ Million) Table 190. China Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2026) & (K Units) Table 191. China Inhalation Pulmonary Drug Delivery Devices Sales by Type (2027-2032) & (K Units) Table 192. China Inhalation Pulmonary Drug Delivery Devices Sales Price by Type (2021-2026) & (US$/Unit) Table 193. China Inhalation Pulmonary Drug Delivery Devices Sales Price by Type (2027-2032) & (US$/Unit) Table 194. China Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2021-2026) & (US$ Million) Table 195. China Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2027-2032) & (US$ Million) Table 196. China Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2026) & (K Units) Table 197. China Inhalation Pulmonary Drug Delivery Devices Sales by Application (2027-2032) & (K Units) Table 198. China Inhalation Pulmonary Drug Delivery Devices Sales Price by Application (2021-2026) & (US$/Unit) Table 199. China Inhalation Pulmonary Drug Delivery Devices Sales Price by Application (2027-2032) & (US$/Unit) Table 200. Asia Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2021-2026) & (US$ Million) Table 201. Asia Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2027-2032) & (US$ Million) Table 202. Asia Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2026) & (K Units) Table 203. Asia Inhalation Pulmonary Drug Delivery Devices Sales by Type (2027-2032) & (K Units) Table 204. Asia Inhalation Pulmonary Drug Delivery Devices Sales Price by Type (2021-2026) & (US$/Unit) Table 205. Asia Inhalation Pulmonary Drug Delivery Devices Sales Price by Type (2027-2032) & (US$/Unit) Table 206. Asia Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2021-2026) & (US$ Million) Table 207. Asia Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2027-2032) & (US$ Million) Table 208. Asia Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2026) & (K Units) Table 209. Asia Inhalation Pulmonary Drug Delivery Devices Sales by Application (2027-2032) & (K Units) Table 210. Asia Inhalation Pulmonary Drug Delivery Devices Sales Price by Application (2021-2026) & (US$/Unit) Table 211. Asia Inhalation Pulmonary Drug Delivery Devices Sales Price by Application (2027-2032) & (US$/Unit) Table 212. Asia Inhalation Pulmonary Drug Delivery Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 213. Asia Inhalation Pulmonary Drug Delivery Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 214. Asia Inhalation Pulmonary Drug Delivery Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 215. Asia Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 216. Asia Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2026) & (K Units) Table 217. Asia Inhalation Pulmonary Drug Delivery Devices Sales by Country (2027-2032) & (K Units) Table 218. Asia Inhalation Pulmonary Drug Delivery Devices Sales Price by Country (2021-2026) & (US$/Unit) Table 219. Asia Inhalation Pulmonary Drug Delivery Devices Sales Price by Country (2027-2032) & (US$/Unit) Table 220. Japan Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 221. South Korea Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 222. India Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 223. Australia Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 224. Taiwan Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 225. Southeast Asia Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 226. SAMEA Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2021-2026) & (US$ Million) Table 227. SAMEA Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2027-2032) & (US$ Million) Table 228. SAMEA Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2026) & (K Units) Table 229. SAMEA Inhalation Pulmonary Drug Delivery Devices Sales by Type (2027-2032) & (K Units) Table 230. SAMEA Inhalation Pulmonary Drug Delivery Devices Sales Price by Type (2021-2026) & (US$/Unit) Table 231. SAMEA Inhalation Pulmonary Drug Delivery Devices Sales Price by Type (2027-2032) & (US$/Unit) Table 232. SAMEA Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2021-2026) & (US$ Million) Table 233. SAMEA Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2027-2032) & (US$ Million) Table 234. SAMEA Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2026) & (K Units) Table 235. SAMEA Inhalation Pulmonary Drug Delivery Devices Sales by Application (2027-2032) & (K Units) Table 236. SAMEA Inhalation Pulmonary Drug Delivery Devices Sales Price by Application (2021-2026) & (US$/Unit) Table 237. SAMEA Inhalation Pulmonary Drug Delivery Devices Sales Price by Application (2027-2032) & (US$/Unit) Table 238. SAMEA Inhalation Pulmonary Drug Delivery Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 239. SAMEA Inhalation Pulmonary Drug Delivery Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 240. SAMEA Inhalation Pulmonary Drug Delivery Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 241. SAMEA Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 242. SAMEA Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2026) & (K Units) Table 243. SAMEA Inhalation Pulmonary Drug Delivery Devices Sales by Country (2027-2032) & (K Units) Table 244. SAMEA Inhalation Pulmonary Drug Delivery Devices Sales Price by Country (2021-2026) & (US$/Unit) Table 245. SAMEA Inhalation Pulmonary Drug Delivery Devices Sales Price by Country (2027-2032) & (US$/Unit) Table 246. Brazil Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 247. Argentina Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 248. Chile Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 249. Colombia Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 250. Peru Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 251. Saudi Arabia Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 252. Israel Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 253. UAE Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 254. Turkey Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 255. Iran Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 256. Egypt Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Table 257. Key Raw Materials Table 258. Raw Materials Key Suppliers Table 259. Inhalation Pulmonary Drug Delivery Devices Distributors List Table 260. Inhalation Pulmonary Drug Delivery Devices Customers List Table 261. Research Programs/Design for This Report Table 262. Authors List of This Report Table 263. Secondary Sources Table 264. Primary Sources List of Figures Figure 1. Inhalation Pulmonary Drug Delivery Devices Image Figure 2. Global Inhalation Pulmonary Drug Delivery Devices Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhalation Pulmonary Drug Delivery Devices Market Size Share 2021 VS 2025 VS 2032 Figure 4. Nebulizers Image Figure 5. Dry-powder Inhalers Image Figure 6. Metered- dose Inhalers Image Figure 7. Global Inhalation Pulmonary Drug Delivery Devices Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Inhalation Pulmonary Drug Delivery Devices Market Size Share 2021 VS 2025 VS 2032 Figure 9. Chronic Obstructive Pulmonary Disease (COPD) Image Figure 10. Cystic Fibrosis (CF) Image Figure 11. Idiopathic Pulmonary Fibrosis (IPF) Image Figure 12. Asthma Image Figure 13. Others Image Figure 14. Global Inhalation Pulmonary Drug Delivery Devices Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Figure 16. Global Inhalation Pulmonary Drug Delivery Devices Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Region (2021-2032) Figure 19. Global Inhalation Pulmonary Drug Delivery Devices Sales (2021-2032) & (K Units) Figure 20. Global Inhalation Pulmonary Drug Delivery Devices Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Inhalation Pulmonary Drug Delivery Devices Sales YoY (2021-2032) & (K Units) Figure 23. Europe Inhalation Pulmonary Drug Delivery Devices Sales YoY (2021-2032) & (K Units) Figure 24. China Inhalation Pulmonary Drug Delivery Devices Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Inhalation Pulmonary Drug Delivery Devices Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales YoY (2021-2032) & (K Units) Figure 27. Global Inhalation Pulmonary Drug Delivery Devices Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Inhalation Pulmonary Drug Delivery Devices Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Type (2021-2032) Figure 33. Global Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Type (2021-2032) Figure 36. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Application (2021-2032) Figure 39. Global Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Application (2021-2032) Figure 42. North America Inhalation Pulmonary Drug Delivery Devices Revenue Share by Type (2021-2032) Figure 43. North America Inhalation Pulmonary Drug Delivery Devices Sales Share by Type (2021-2032) Figure 44. North America Inhalation Pulmonary Drug Delivery Devices Revenue Share by Application (2021-2032) Figure 45. North America Inhalation Pulmonary Drug Delivery Devices Sales Share by Application (2021-2032) Figure 46. North America Inhalation Pulmonary Drug Delivery Devices Revenue Share by Country (2021-2032) Figure 47. North America Inhalation Pulmonary Drug Delivery Devices Sales Share by Country (2021-2032) Figure 48. Europe Inhalation Pulmonary Drug Delivery Devices Revenue Share by Type (2021-2032) Figure 49. Europe Inhalation Pulmonary Drug Delivery Devices Sales Share by Type (2021-2032) Figure 50. Europe Inhalation Pulmonary Drug Delivery Devices Revenue Share by Application (2021-2032) Figure 51. Europe Inhalation Pulmonary Drug Delivery Devices Sales Share by Application (2021-2032) Figure 52. Europe Inhalation Pulmonary Drug Delivery Devices Revenue Share by Country (2021-2032) Figure 53. Europe Inhalation Pulmonary Drug Delivery Devices Sales Share by Country (2021-2032) Figure 54. China Inhalation Pulmonary Drug Delivery Devices Revenue Share by Type (2021-2032) Figure 55. China Inhalation Pulmonary Drug Delivery Devices Sales Share by Type (2021-2032) Figure 56. China Inhalation Pulmonary Drug Delivery Devices Revenue Share by Application (2021-2032) Figure 57. China Inhalation Pulmonary Drug Delivery Devices Sales Share by Application (2021-2032) Figure 58. Asia Inhalation Pulmonary Drug Delivery Devices Revenue Share by Type (2021-2032) Figure 59. Asia Inhalation Pulmonary Drug Delivery Devices Sales Share by Type (2021-2032) Figure 60. Asia Inhalation Pulmonary Drug Delivery Devices Revenue Share by Application (2021-2032) Figure 61. Asia Inhalation Pulmonary Drug Delivery Devices Sales Share by Application (2021-2032) Figure 62. Asia Inhalation Pulmonary Drug Delivery Devices Revenue Share by Country (2021-2032) Figure 63. Asia Inhalation Pulmonary Drug Delivery Devices Sales Share by Country (2021-2032) Figure 64. SAMEA Inhalation Pulmonary Drug Delivery Devices Revenue Share by Type (2021-2032) Figure 65. SAMEA Inhalation Pulmonary Drug Delivery Devices Sales Share by Type (2021-2032) Figure 66. SAMEA Inhalation Pulmonary Drug Delivery Devices Revenue Share by Application (2021-2032) Figure 67. SAMEA Inhalation Pulmonary Drug Delive

Scope & coverage.

Types
  • Nebulizers
  • Dry-powder Inhalers
  • Metered- dose Inhalers
Applications
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis (CF)
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Asthma
  • Others
Companies covered
  • AptarGroup
  • Boehringer Ingelheim
  • Chiesi Farmaceutici
  • H&T Presspart
  • Koninklijke Philips
  • Monaghan Medical
  • OMRON
  • PARI International
  • Vectura
  • AstraZeneca
  • GlaxoSmithKline (GSK)
  • Viatris
  • Merck
  • Novartis
  • Teva Pharmaceutical Industries

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Inhalation Pulmonary Drug Delivery Devices Market by Type
  3. 1.2.1 Global Inhalation Pulmonary Drug Delivery Devices Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Nebulizers
  5. 1.2.3 Dry-powder Inhalers
  6. 1.2.4 Metered- dose Inhalers
  7. 1.3 Inhalation Pulmonary Drug Delivery Devices Market by Application
  8. 1.3.1 Global Inhalation Pulmonary Drug Delivery Devices Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Chronic Obstructive Pulmonary Disease (COPD)
  10. 1.3.3 Cystic Fibrosis (CF)
  11. 1.3.4 Idiopathic Pulmonary Fibrosis (IPF)
  12. 1.3.5 Asthma
  13. 1.3.6 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Inhalation Pulmonary Drug Delivery Devices Market Dynamics
  1. 2.1 Inhalation Pulmonary Drug Delivery Devices Industry Trends
  2. 2.2 Inhalation Pulmonary Drug Delivery Devices Industry Drivers
  3. 2.3 Inhalation Pulmonary Drug Delivery Devices Industry Opportunities and Challenges
  4. 2.4 Inhalation Pulmonary Drug Delivery Devices Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Inhalation Pulmonary Drug Delivery Devices Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Region
  3. 3.2.1 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Region (2021-2026)
  5. 3.2.3 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Region (2027-2032)
  6. 3.2.4 Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Inhalation Pulmonary Drug Delivery Devices Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Inhalation Pulmonary Drug Delivery Devices Sales by Region
  9. 3.4.1 Global Inhalation Pulmonary Drug Delivery Devices Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Inhalation Pulmonary Drug Delivery Devices Sales by Region (2021-2026)
  11. 3.4.3 Global Inhalation Pulmonary Drug Delivery Devices Sales by Region (2027-2032)
  12. 3.4.4 Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Manufacturers
  2. 4.1.1 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Inhalation Pulmonary Drug Delivery Devices Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Inhalation Pulmonary Drug Delivery Devices Sales by Manufacturers
  6. 4.2.1 Global Inhalation Pulmonary Drug Delivery Devices Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Inhalation Pulmonary Drug Delivery Devices Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Inhalation Pulmonary Drug Delivery Devices Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Inhalation Pulmonary Drug Delivery Devices Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Inhalation Pulmonary Drug Delivery Devices Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Inhalation Pulmonary Drug Delivery Devices Manufacturers, Product Type & Application
  13. 4.7 Global Inhalation Pulmonary Drug Delivery Devices Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Inhalation Pulmonary Drug Delivery Devices Market CR5 and HHI
  16. 4.8.2 2025 Inhalation Pulmonary Drug Delivery Devices Tier 1, Tier 2, and Tier 3
5 Inhalation Pulmonary Drug Delivery Devices Market by Type
  1. 5.1 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Type
  2. 5.1.1 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Inhalation Pulmonary Drug Delivery Devices Sales by Type
  6. 5.2.1 Global Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Type (2021-2032)
  9. 5.3 Global Inhalation Pulmonary Drug Delivery Devices Price by Type
6 Inhalation Pulmonary Drug Delivery Devices Market by Application
  1. 6.1 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Application
  2. 6.1.1 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Inhalation Pulmonary Drug Delivery Devices Sales by Application
  6. 6.2.1 Global Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Application (2021-2032)
  9. 6.3 Global Inhalation Pulmonary Drug Delivery Devices Price by Application
7 Company Profiles
  1. 7.1 AptarGroup
  2. 7.1.1 AptarGroup Company Information
  3. 7.1.2 AptarGroup Business Overview
  4. 7.1.3 AptarGroup Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 AptarGroup Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  6. 7.1.5 AptarGroup Recent Developments
  7. 7.2 Boehringer Ingelheim
  8. 7.2.1 Boehringer Ingelheim Company Information
  9. 7.2.2 Boehringer Ingelheim Business Overview
  10. 7.2.3 Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  12. 7.2.5 Boehringer Ingelheim Recent Developments
  13. 7.3 Chiesi Farmaceutici
  14. 7.3.1 Chiesi Farmaceutici Company Information
  15. 7.3.2 Chiesi Farmaceutici Business Overview
  16. 7.3.3 Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  18. 7.3.5 Chiesi Farmaceutici Recent Developments
  19. 7.4 H&T Presspart
  20. 7.4.1 H&T Presspart Company Information
  21. 7.4.2 H&T Presspart Business Overview
  22. 7.4.3 H&T Presspart Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 H&T Presspart Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  24. 7.4.5 H&T Presspart Recent Developments
  25. 7.5 Koninklijke Philips
  26. 7.5.1 Koninklijke Philips Company Information
  27. 7.5.2 Koninklijke Philips Business Overview
  28. 7.5.3 Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  30. 7.5.5 Koninklijke Philips Recent Developments
  31. 7.6 Monaghan Medical
  32. 7.6.1 Monaghan Medical Company Information
  33. 7.6.2 Monaghan Medical Business Overview
  34. 7.6.3 Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  36. 7.6.5 Monaghan Medical Recent Developments
  37. 7.7 OMRON
  38. 7.7.1 OMRON Company Information
  39. 7.7.2 OMRON Business Overview
  40. 7.7.3 OMRON Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 OMRON Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  42. 7.7.5 OMRON Recent Developments
  43. 7.8 PARI International
  44. 7.8.1 PARI International Company Information
  45. 7.8.2 PARI International Business Overview
  46. 7.8.3 PARI International Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 PARI International Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  48. 7.8.5 PARI International Recent Developments
  49. 7.9 Vectura
  50. 7.9.1 Vectura Company Information
  51. 7.9.2 Vectura Business Overview
  52. 7.9.3 Vectura Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Vectura Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  54. 7.9.5 Vectura Recent Developments
  55. 7.10 AstraZeneca
  56. 7.10.1 AstraZeneca Company Information
  57. 7.10.2 AstraZeneca Business Overview
  58. 7.10.3 AstraZeneca Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 AstraZeneca Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  60. 7.10.5 AstraZeneca Recent Developments
  61. 7.11 GlaxoSmithKline (GSK)
  62. 7.11.1 GlaxoSmithKline (GSK) Company Information
  63. 7.11.2 GlaxoSmithKline (GSK) Business Overview
  64. 7.11.3 GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  66. 7.11.5 GlaxoSmithKline (GSK) Recent Developments
  67. 7.12 Viatris
  68. 7.12.1 Viatris Company Information
  69. 7.12.2 Viatris Business Overview
  70. 7.12.3 Viatris Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Viatris Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  72. 7.12.5 Viatris Recent Developments
  73. 7.13 Merck
  74. 7.13.1 Merck Company Information
  75. 7.13.2 Merck Business Overview
  76. 7.13.3 Merck Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Merck Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  78. 7.13.5 Merck Recent Developments
  79. 7.14 Novartis
  80. 7.14.1 Novartis Company Information
  81. 7.14.2 Novartis Business Overview
  82. 7.14.3 Novartis Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Novartis Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  84. 7.14.5 Novartis Recent Developments
  85. 7.15 Teva Pharmaceutical Industries
  86. 7.15.1 Teva Pharmaceutical Industries Company Information
  87. 7.15.2 Teva Pharmaceutical Industries Business Overview
  88. 7.15.3 Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  90. 7.15.5 Teva Pharmaceutical Industries Recent Developments
8 North America
  1. 8.1 North America Inhalation Pulmonary Drug Delivery Devices Market Size by Type
  2. 8.1.1 North America Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2021-2032)
  3. 8.1.2 North America Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2032)
  4. 8.1.3 North America Inhalation Pulmonary Drug Delivery Devices Price by Type (2021-2032)
  5. 8.2 North America Inhalation Pulmonary Drug Delivery Devices Market Size by Application
  6. 8.2.1 North America Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2021-2032)
  7. 8.2.2 North America Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2032)
  8. 8.2.3 North America Inhalation Pulmonary Drug Delivery Devices Price by Application (2021-2032)
  9. 8.3 North America Inhalation Pulmonary Drug Delivery Devices Market Size by Country
  10. 8.3.1 North America Inhalation Pulmonary Drug Delivery Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Inhalation Pulmonary Drug Delivery Devices Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Inhalation Pulmonary Drug Delivery Devices Market Size by Type
  2. 9.1.1 Europe Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2021-2032)
  3. 9.1.2 Europe Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2032)
  4. 9.1.3 Europe Inhalation Pulmonary Drug Delivery Devices Price by Type (2021-2032)
  5. 9.2 Europe Inhalation Pulmonary Drug Delivery Devices Market Size by Application
  6. 9.2.1 Europe Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2021-2032)
  7. 9.2.2 Europe Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2032)
  8. 9.2.3 Europe Inhalation Pulmonary Drug Delivery Devices Price by Application (2021-2032)
  9. 9.3 Europe Inhalation Pulmonary Drug Delivery Devices Market Size by Country
  10. 9.3.1 Europe Inhalation Pulmonary Drug Delivery Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Inhalation Pulmonary Drug Delivery Devices Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Inhalation Pulmonary Drug Delivery Devices Market Size by Type
  2. 10.1.1 China Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2021-2032)
  3. 10.1.2 China Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2032)
  4. 10.1.3 China Inhalation Pulmonary Drug Delivery Devices Price by Type (2021-2032)
  5. 10.2 China Inhalation Pulmonary Drug Delivery Devices Market Size by Application
  6. 10.2.1 China Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2021-2032)
  7. 10.2.2 China Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2032)
  8. 10.2.3 China Inhalation Pulmonary Drug Delivery Devices Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Inhalation Pulmonary Drug Delivery Devices Market Size by Type
  2. 11.1.1 Asia Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2021-2032)
  3. 11.1.2 Asia Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2032)
  4. 11.1.3 Asia Inhalation Pulmonary Drug Delivery Devices Price by Type (2021-2032)
  5. 11.2 Asia Inhalation Pulmonary Drug Delivery Devices Market Size by Application
  6. 11.2.1 Asia Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2021-2032)
  7. 11.2.2 Asia Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2032)
  8. 11.2.3 Asia Inhalation Pulmonary Drug Delivery Devices Price by Application (2021-2032)
  9. 11.3 Asia Inhalation Pulmonary Drug Delivery Devices Market Size by Country
  10. 11.3.1 Asia Inhalation Pulmonary Drug Delivery Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Inhalation Pulmonary Drug Delivery Devices Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Inhalation Pulmonary Drug Delivery Devices Market Size by Type
  2. 12.1.1 SAMEA Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Inhalation Pulmonary Drug Delivery Devices Price by Type (2021-2032)
  5. 12.2 SAMEA Inhalation Pulmonary Drug Delivery Devices Market Size by Application
  6. 12.2.1 SAMEA Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Inhalation Pulmonary Drug Delivery Devices Price by Application (2021-2032)
  9. 12.3 SAMEA Inhalation Pulmonary Drug Delivery Devices Market Size by Country
  10. 12.3.1 SAMEA Inhalation Pulmonary Drug Delivery Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Inhalation Pulmonary Drug Delivery Devices Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Inhalation Pulmonary Drug Delivery Devices Value Chain Analysis
  2. 13.1.1 Inhalation Pulmonary Drug Delivery Devices Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Inhalation Pulmonary Drug Delivery Devices Production Mode & Process
  6. 13.2 Inhalation Pulmonary Drug Delivery Devices Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Inhalation Pulmonary Drug Delivery Devices Distributors
  9. 13.2.3 Inhalation Pulmonary Drug Delivery Devices Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst